Alzheimer’s Drug Production a Step Closer With the Help of Bacteria and AI

Photo source: iStock. Article by Sarah Whelan, PhD.  Technology Networks: Biopharma – March 15, 2024. Press release: The University of Texas at Austin. Study: Nature Communications.

Galantamine is a drug commonly used to treat the symptoms of mild to moderate dementia, a sign of Alzheimer’s disease. Its active ingredients are extracted in a time-consuming process from daffodils. Daffodil harvesting can be unpredictable due to variations […]

Click here to view original web page at www.technologynetworks.com